Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Scientist Award (K05)
Project #
5K05DA000220-03
Application #
2116182
Study Section
Special Emphasis Panel (SRCD (04))
Project Start
1994-08-01
Project End
1999-07-31
Budget Start
1996-08-01
Budget End
1997-07-31
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Faskowitz, Andrew J; Kramskiy, Vladimir N; Pasternak, Gavril W (2013) Methadone-induced hypoglycemia. Cell Mol Neurobiol 33:537-42
Pasternak, Gavril W; Pan, Ying-Xian (2013) Mu opioids and their receptors: evolution of a concept. Pharmacol Rev 65:1257-317
Su, Wendy; Pasternak, Gavril W (2013) The role of multidrug resistance-associated protein in the blood-brain barrier and opioid analgesia. Synapse 67:609-19
Kim, Felix J; Schrock, Joel M; Spino, Christina M et al. (2012) Inhibition of tumor cell growth by Sigma1 ligand mediated translational repression. Biochem Biophys Res Commun 426:177-82
Majumdar, Susruta; Burgman, Maxim; Haselton, Nathan et al. (2011) Generation of novel radiolabeled opiates through site-selective iodination. Bioorg Med Chem Lett 21:4001-4
Kim, Felix J; Kovalyshyn, Ivanka; Burgman, Maxim et al. (2010) Sigma 1 receptor modulation of G-protein-coupled receptor signaling: potentiation of opioid transduction independent from receptor binding. Mol Pharmacol 77:695-703
Kolesnikov, Yuri A; Oksman, Galina; Pasternak, Gavril W (2010) Topical methadone and meperidine analgesic synergy in the mouse. Eur J Pharmacol 638:61-4
Rossi, Grace C; Matulonis, Joshua E; Richelson, Elliott et al. (2010) Systemically and topically active antinociceptive neurotensin compounds. J Pharmacol Exp Ther 334:1075-9
Pasternak, Gavril W (2010) Molecular insights into mu opioid pharmacology: From the clinic to the bench. Clin J Pain 26 Suppl 10:S3-9
Chou, Roger; Fanciullo, Gilbert J; Fine, Perry G et al. (2009) Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 10:113-30

Showing the most recent 10 out of 22 publications